Protein Engineering

Biography

John Gu is the President and CSO of Renascions, a precision medicine company in pharmaceutical development. He is an adjunct professor in the Molecular Pharmacology Department at City of Hope, and was a program director at Sidney Kimmel Cancer Center. He received his Ph.D in Chemistry, and was the recipient of the NIH Fellowship for the Human Genome Project at Washington University School of Medicine in St Louis. He worked on the discovery and applications of genome-wide SNPs and built a foundation for high density DNA microarray using in SNP mapping. His scientific focuses include developing clinical applications for GWAS SNP data, and his most recent interest is usingReAL, a proprietary technology, to measure, predict, and improve the clinical outcomes in genetic predisposition subpopulations. ReAL has been used in various clinical programs in collaborations with industrial partners, and has achieved outstanding results. In addition, Renascions is currently working on a T2D drug in clinical stages. Dr. Gu previously worked as a senior scientific staff and section head at Motorola Life Sciences, and as an executive at Vita Genomics, Shanghai GeneCore Biotechnologies, and CytoPharm Therapeutics. He also serves as a board director at Global Oceanic and Parallel 6.

Research Interest

Applications of genome-wide SNPs and built a foundation for high density DNA microarray using in SNP mapping